Fifth disease
☆ Fir-riżultati ta' Stiftung Warentest tal-2022 mill-Ġermanja, is-sodisfazzjon tal-konsumatur b'ModelDerm kien biss ftit inqas milli b'konsultazzjonijiet bit-telemediċina mħallsa.
Tagħha ta' 16-il xahar b'Fifth disease ― Iż-żewġ ħaddejn isiru ħomor, bħallikieku jiġu slapped, u raxx makulopapulari jidhru fuq il-ġisem.
Eritema fuq iż-żewġ ħaddejn.
References
Fifth disease , magħrufa wkoll bħala erythema infectiosum, hija infezzjoni virali kkawżata minn parvovirus uman B19. Hija aktar prevalenti fit-tfal, tipikament taffettwa lil dawk bejn l-4 u l-14-il sena. Is-sintomi ta’ spiss jibdew b’deni ħafif, uġigħ ta’ ras, uġigħ fil-griżmejn, u sentimenti simili għall-influwenza. It-tfal jistgħu jiżviluppaw raxx aħmar distint fuq il-wiċċ li jixbaħ slapped cheeks , flimkien ma 'raxx b'disinn fuq il-ġisem, id-dirgħajn u s-saqajn. Fl-adulti, uġigħ fil-ġogi huwa ilment komuni, li jista 'jidher ġimgħat wara l-infezzjoni inizjali. Notevolment, madwar 20 sa 30% tal-adulti infettati bil-parvovirus B19 jistgħu ma juru l-ebda sintomi.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Fifth disease (erythema infectiosum) is a viral infection caused by human parvovirus B19. It is more common in children than adults and usually affects children ages 4 to 14. The disease often starts with mild fever, headache, sore throat, and other flu-like symptoms. Children can also develop a bright red rash on the face that looks like “slapped cheeks”, along with a lacy or bumpy rash on the body, arms, and legs. In adults, joint aches are a common symptom. Rash and joint symptoms may develop several weeks after infection. About 20 to 30% of adults who are infected with parvovirus B19 will not have symptoms.
Ir-riskju li tgħaddi parvovirus B19 minn omm għal tarbija huwa ta’ madwar 33%, b’madwar 3% tan-nisa infettati jesperjenzaw kumplikazzjonijiet fit-trabi tagħhom. Meta l-omm tiġi infettata qabel 20 ġimgħa ta’ tqala, iċ-ċansijiet ta’ kumplikazzjonijiet bħal problemi tad-demm u akkumulazzjoni ta’ fluwidu fil-ġisem tat-tarbija jiżdiedu. Biex tibda timmaniġġja din il-marda, għandna niċċekkjaw jekk il-pazjent qattx ġie espost għal parvovirus billi nittestjaw għal ċerti antikorpi (IgM) . Jekk it-test ma juri l-ebda espożizzjoni fil-passat iżda jindika infezzjoni reċenti, il-pazjent jeħtieġ monitoraġġ mill-qrib waqt it-tqala, inklużi skans regolari bl-ultrasound biex jiċċekkja għal ċerti kwistjonijiet ta 'saħħa tat-trabi.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
The rate of vertical transmission during maternal parvovirus B19 infection is estimated at 33%, with fetal complications occurring in 3% of infected women. Fetal complications comprising hemolysis, anemia, and nonimmune hydrops fetalis and fetal loss are more frequent when maternal infection occurs before 20 weeks of gestation. The first step in the management of this patient would be to obtain immunoglobulin (Ig) M and IgG titres against parvovirus to evaluate if the patient has had previous immunity against the disease. If results are negative for IgG but positive for IgM (ie, primary infection), this patient would need close obstetrical monitoring for the following weeks, including serial ultrasounds to rule out fetal anemia and hydrops fetalis.
Fifth disease jibda b'deni baxx, uġigħ ta' ras, raxx, u sintomi bħal riħ, bħal imnieħer inixxi jew misdud. Dawn is-sintomi jgħaddu, imbagħad ftit jiem wara, ir-raxx jidher. Ir-raxx aħmar jgħajjat l-aktar jidher fil-wiċċ, partikolarment il-ħaddejn. (għalhekk l-isem "marda tal-ħaddejn slapped"). Minbarra ħaddejn ħomor, it-tfal spiss jiżviluppaw raxx aħmar u bizzilla fuq il-bqija tal-ġisem, bil-parti ta 'fuq tad-dirgħajn, it-torso, u r-riġlejn ikunu l-aktar postijiet komuni.
Il-marda hija ġeneralment ħafifa, iżda fin-nisa tqal, l-infezzjoni fl-ewwel trimestru ġiet marbuta ma 'hydrops fetalis, li tikkawża korriment spontanju.
○ Trattament
L-ebda trattament speċifiku mhu meħtieġ peress li ġeneralment jitjieb maż-żmien.